THURSDAY, Feb. 9, 2023 (HealthDay News) — A single injection of an experimental biologic drug may cut in half your risk of hospitalization from COVID-19 infection, new clinical trial results show. Pegylated lambda interferon (PEG-lambda) proved effective against all COVID-19 variants encountered in this international study, including Omicron, according toContinue Reading

TUESDAY, Feb. 7, 2023 (HealthDay News) — Kidney disease patients on dialysis are 100 times more likely to contract a dangerous blood infection than people not receiving the treatment — and that risk is borne primarily by Hispanic and Black Americans, U.S. government health officials say. Hispanic patients are 40%Continue Reading

MONDAY, Jan. 30, 2023 (HealthDay News) — The pandemic has reached a “transition point,” the World Health Organization (WHO) said Monday. Still, that doesn’t mean the public health emergency of international concern (PHEIC) designation declared by the WHO in January 2020 is over yet. The organization’s International Health Regulations EmergencyContinue Reading